Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

88.51
-2.2100-2.44%
Post-market: 88.510.00000.00%19:16 EDT
Volume:2.23M
Turnover:197.92M
Market Cap:5.34B
PE:-188.32
High:91.70
Open:90.73
Low:86.90
Close:90.72
52wk High:109.28
52wk Low:36.88
Shares:60.34M
Float Shares:39.99M
Volume Ratio:2.62
T/O Rate:5.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4700
EPS(LYR):-0.4700
ROE:-8.65%
ROA:-1.83%
PB:16.97
PE(LYR):-188.32

Loading ...

Aug 18, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 16, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 06, 2022

Major Issues Report

8-K - Current report
May 23, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 09, 2022

Major Issues Report

8-K - Current report
Mar 09, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Nov 19, 2021

Major Issues Report

8-K - Current report